- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Patients With Multiple Sclerosis in United Kingdom
Total 1675 results
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Israel, Italy, Lithuania, North Macedonia, Poland, Puerto Rico, Romania, Russian Federation, Slovakia, South Africa, Spain, Ukraine
-
Immunic AGActive, not recruitingMultiple SclerosisUnited States, Germany, Netherlands, Bulgaria, Serbia, Canada, Czechia, Moldova, Republic of, North Macedonia, Poland, Romania, Ukraine
-
TG Therapeutics, Inc.RecruitingA Study Evaluating the Presence and Concentration of BRIUMVI™ (Ublituximab) in Breast Milk (PROVIDE)Relapsing Multiple SclerosisUnited States
-
University of California, San DiegoCompletedMultiple Sclerosis (MS)United States
-
SanofiActive, not recruitingSecondary Progressive Multiple SclerosisUnited States, Argentina, Belgium, Canada, Czechia, France, Germany, Greece, India, Israel, Netherlands, Norway, Portugal, Turkey, United Kingdom, Japan, Austria, Bulgaria, China, Denmark, Finland, Italy, Lithuania, Poland, Romania, Russian... and more
-
Genentech, Inc.Roche Pharma AGCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada, Belgium, Spain, France, Switzerland, Ukraine, Mexico, Germany, Bulgaria, United Kingdom, Romania, Czechia, Italy, Russian Federation, Serbia, Slovakia, Denmark
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, Hungary, Brazil, Finland, Italy, Germany, Romania, Lithuania, France, Greece, Peru, Portugal, Spain, Switzerland, Bulgaria, Ukraine, Israel, Poland, Austria, New Zealand, Netherlands, Belgium, Mexico, United... and more
-
Kessler FoundationHackensack Meridian HealthRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompletedRelapsing Forms of Multiple SclerosisUnited States
-
University of VermontCompletedFatigue | Sleep Initiation and Maintenance Disorders | Relapsing Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsRecruitingMultiple Sclerosis (MS)United States, Belgium, Spain, Taiwan, Italy, Germany, Canada, Estonia, Mexico, Croatia, Slovakia, Turkey, India, Argentina, France, Israel, Australia, Austria, Serbia, Brazil, Guatemala, Latvia, Poland, Portugal, Russian Federation, Romania and more
-
University of WashingtonRecruitingFatigue | Multiple Sclerosis (MS) | Physical InactivityUnited States
-
VA Office of Research and DevelopmentOregon Health and Science UniversityCompletedMultiple Sclerosis, Chronic ProgressiveUnited States
-
BiogenRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
City University of New YorkRecruitingMultiple Sclerosis,Gait, ExerciseUnited States
-
Wayne State UniversityRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Johns Hopkins UniversityGenentech, Inc.Active, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Providence Health & ServicesMicrostein, LLCCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Rush University Medical CenterCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Transparency Life SciencesUnknownMultiple Sclerosis, Relapsing-RemittingUnited States
-
Nelson Mandela Metropolitan UniversityUnknownMultiple Sclerosis, Relapsing-RemittingUnited States
-
University of California, San FranciscoGenentech, Inc.; Valhalla FoundationActive, not recruitingClinically Isolated Syndrome | Relapsing Multiple SclerosisUnited States
-
Cedars-Sinai Medical CenterRecruitingMultiple Sclerosis | Clinically Isolated Syndrome | Multiple Sclerosis, Relapsing-Remitting | Healthy Aging | Neurologic Disorder | Neuromyelitis Optica Spectrum Disorders | Radiologically Isolated Syndrome | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary Progressive | Neurologic... and other conditionsUnited States
-
Washington University School of MedicineEMD SeronoActive, not recruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Scripps HealthWithdrawnMultiple Sclerosis, Relapsing-RemittingUnited States
-
University College, LondonCompletedMultiple Sclerosis | Overactive BladderUnited Kingdom
-
CelgeneNot yet recruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
National Institute of Allergy and Infectious Diseases...Novartis Pharmaceuticals; Autoimmunity Centers of ExcellenceCompletedSecondary Progressive Multiple SclerosisUnited States
-
Brigham and Women's HospitalWithdrawnPatients With Acute PancreatitisUnited States
-
Cardiff UniversityNovartisUnknownTuberous SclerosisUnited Kingdom
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Spain
-
Hoffmann-La RocheActive, not recruitingRelapsing Multiple SclerosisUnited States, Korea, Republic of, India, Brazil, Poland, Canada, Bulgaria, United Kingdom, France, Greece, Italy, Russian Federation, Turkey, Mexico, Austria, Denmark, Guatemala
-
Washington University School of MedicineBiogenWithdrawnMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Cornerstone Health Care, PABiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Spain, Canada, Australia, Germany, Italy, United Kingdom, Belgium, Netherlands, France, Israel
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingAustralia, France, United States, Germany, Canada, United Kingdom, Russian Federation, Argentina, Brazil, Croatia, Poland, Serbia, Sweden, Ukraine, Czech Republic, Mexico
-
East Kent Hospitals University NHS Foundation TrustCompletedCerebral Stroke | Chronic Brain Injury | MS (Multiple Sclerosis)United Kingdom
-
Loxo Oncology, Inc.Eli Lilly and CompanyWithdrawnMultiple Sclerosis | Relapsing Multiple SclerosisUnited States, Puerto Rico
-
University of PennsylvaniaUniversity of PittsburghCompletedThis Study Will Focus on Advance Care Planning Among Patients With Life-limiting IllnessesUnited States
-
BiogenTerminatedRelapsing Multiple SclerosisUnited States
-
Novartis PharmaceuticalsActive, not recruitingRelapsing Multiple SclerosisUnited States, Poland, Austria, Belgium, Czechia, Germany, Australia, Switzerland, Lebanon, Argentina, Canada, Slovenia, Bulgaria, Latvia, Russian Federation, Spain, Italy, Turkey, Slovakia, Portugal, Greece, Saudi Arabia, Hungary, No... and more
-
Bristol-Myers SquibbActive, not recruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Hoffmann-La RocheCompletedRelapsing Multiple SclerosisUnited States, Spain, Czechia, Belgium, Italy, Canada, United Kingdom, Germany, Ireland, Turkey, Poland, Russian Federation, Ukraine, Croatia, Argentina, France, Belarus, Brazil, Mexico, Bosnia and Herzegovina, Bulgaria, Slovakia, S... and more
-
Novartis PharmaceuticalsCompletedRelapsing Forms of Multiple SclerosisAustralia, United States
-
Johns Hopkins UniversityPatient-Centered Outcomes Research InstituteCompletedFatigue in Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Central Nervous System (CNS) Demyelinating DiseaseUnited Kingdom
-
University of Southern CaliforniaTeva Pharmaceuticals USACompletedRelapsing Remitting Multiple SclerosisUnited States
-
Jazz PharmaceuticalsTerminatedMultiple Sclerosis (MS)United States, Poland, Czechia, United Kingdom, Romania
-
Massachusetts General HospitalWithdrawn
-
The University of Texas Health Science Center,...Microsoft HoustonTerminatedPediatric Onset Multiple Sclerosis (POMS)United States